Loading clinical trials...
Loading clinical trials...
COBRA PzF Stenting to Reduce the Duration of Triple Therapy in Patients Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
Conditions
Interventions
COBRA PzF
Drug Eluting Stent
Locations
48
United States
Christiana Care Health Services
Newark, Delaware, United States
University of Florida
Jacksonville, Florida, United States
Memorial Hospital Jacksonville
Jacksonville, Florida, United States
Sebastian River Medical Center
Melbourne, Florida, United States
Mt Sinai Medical Center
Miami Beach, Florida, United States
Augusta University
Augusta, Georgia, United States
Start Date
February 5, 2016
Primary Completion Date
May 1, 2021
Completion Date
November 1, 2021
Last Updated
October 26, 2020
NCT07444957
NCT06387693
NCT07183605
NCT04861103
NCT07174206
NCT06868823
Lead Sponsor
CeloNova BioSciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions